Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nintedanib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nintedanibmarket, defines the market attractiveness level of Nintedanib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nintedanib industry, describes the types of Nintedanib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nintedanib market and the development prospects and opportunities of Nintedanib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nintedanib market in Chapter 13.
By Player:
Haosen Pharmaceutical Industry
Glenmark
Sichuan KELUN PHARMACEUTICAL Co, Ltd
Simcere Pharmaceutical
Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd
Shiyao Group Enbipu Pharmaceutical Industry Limited Company
Qingfeng Pharmaceutical Industry
Boehringer Ingelheim Pharma
By Type:
100mg*10 Capsules
150mg*10 Capsules
100mg*30 Capsules
150mg*30 Capsules
150mg*60 Capsules
By End-User:
Locally Advanced NSCLC
Variant NSCLC
Locally Recurrent NSCLC
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nintedanib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nintedanib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nintedanib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nintedanib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nintedanib Market Analysis and Outlook to 2022
-
7.1 Global Nintedanib Consumption (2017-2022)
-
7.2 United States Nintedanib Consumption (2017-2022)
-
7.3 Europe Nintedanib Consumption (2017-2022)
-
7.4 China Nintedanib Consumption (2017-2022)
-
7.5 Japan Nintedanib Consumption (2017-2022)
-
7.6 India Nintedanib Consumption (2017-2022)
-
7.7 South Korea Nintedanib Consumption (2017-2022)
8 Region and Country-wise Nintedanib Market Analysis and Outlook to 2028
-
8.1 Global Nintedanib Consumption Forecast (2022-2028)
-
8.2 United States Nintedanib Consumption Forecast (2022-2028)
-
8.3 Europe Nintedanib Consumption Forecast (2022-2028)
-
8.4 China Nintedanib Consumption Forecast (2022-2028)
-
8.5 Japan Nintedanib Consumption Forecast (2022-2028)
-
8.6 India Nintedanib Consumption Forecast (2022-2028)
-
8.7 South Korea Nintedanib Consumption Forecast (2022-2028)
9 Global Nintedanib Market Outlook by Types and Applications to 2022
-
9.1 Global Nintedanib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100mg*10 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 150mg*10 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 100mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 150mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 150mg*60 Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Nintedanib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Locally Advanced NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Variant NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Locally Recurrent NSCLC Consumption and Growth Rate (2017-2022)
10 Global Nintedanib Market Outlook by Types and Applications to 2028
-
10.1 Global Nintedanib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100mg*10 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 150mg*10 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 100mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 150mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 150mg*60 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nintedanib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Locally Advanced NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Variant NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Locally Recurrent NSCLC Consumption Forecast and Growth Rate (2022-2028)
11 Global Nintedanib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nintedanib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nintedanib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nintedanib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nintedanib Market Competitive Analysis
-
14.1 Haosen Pharmaceutical Industry
-
14.1.1 Haosen Pharmaceutical Industry Company Details
-
14.1.2 Haosen Pharmaceutical Industry Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Haosen Pharmaceutical Industry Nintedanib Product and Service
-
14.2 Glenmark
-
14.2.1 Glenmark Company Details
-
14.2.2 Glenmark Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Glenmark Nintedanib Product and Service
-
14.3 Sichuan KELUN PHARMACEUTICAL Co, Ltd
-
14.3.1 Sichuan KELUN PHARMACEUTICAL Co, Ltd Company Details
-
14.3.2 Sichuan KELUN PHARMACEUTICAL Co, Ltd Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sichuan KELUN PHARMACEUTICAL Co, Ltd Nintedanib Product and Service
-
14.4 Simcere Pharmaceutical
-
14.4.1 Simcere Pharmaceutical Company Details
-
14.4.2 Simcere Pharmaceutical Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Simcere Pharmaceutical Nintedanib Product and Service
-
14.5 Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd
-
14.5.1 Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd Company Details
-
14.5.2 Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd Nintedanib Product and Service
-
14.6 Shiyao Group Enbipu Pharmaceutical Industry Limited Company
-
14.6.1 Shiyao Group Enbipu Pharmaceutical Industry Limited Company Company Details
-
14.6.2 Shiyao Group Enbipu Pharmaceutical Industry Limited Company Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shiyao Group Enbipu Pharmaceutical Industry Limited Company Nintedanib Product and Service
-
14.7 Qingfeng Pharmaceutical Industry
-
14.7.1 Qingfeng Pharmaceutical Industry Company Details
-
14.7.2 Qingfeng Pharmaceutical Industry Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Qingfeng Pharmaceutical Industry Nintedanib Product and Service
-
14.8 Boehringer Ingelheim Pharma
-
14.8.1 Boehringer Ingelheim Pharma Company Details
-
14.8.2 Boehringer Ingelheim Pharma Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Pharma Nintedanib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nintedanib
-
Figure Nintedanib Picture
-
Table Global Nintedanib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nintedanib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nintedanib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nintedanib Consumption by Country (2017-2022)
-
Figure United States Nintedanib Consumption and Growth Rate (2017-2022)
-
Table Europe Nintedanib Consumption and Growth Rate (2017-2022)
-
Figure China Nintedanib Consumption and Growth Rate (2017-2022)
-
Figure Japan Nintedanib Consumption and Growth Rate (2017-2022)
-
Figure India Nintedanib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nintedanib Consumption and Growth Rate (2017-2022)
-
Figure Global Nintedanib Consumption Forecast by Country (2022-2028)
-
Figure United States Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nintedanib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg*10 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*10 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*30 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg*60 Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Locally Advanced NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Variant NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Locally Recurrent NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg*10 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*10 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*30 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg*60 Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Locally Advanced NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Variant NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Locally Recurrent NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nintedanib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nintedanib Export by Region (Top 5 Countries) (2017-2028)
-
Table Haosen Pharmaceutical Industry (Foundation Year, Company Profile and etc.)
-
Table Haosen Pharmaceutical Industry Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Haosen Pharmaceutical Industry Nintedanib Product and Service
-
Table Glenmark (Foundation Year, Company Profile and etc.)
-
Table Glenmark Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Nintedanib Product and Service
-
Table Sichuan KELUN PHARMACEUTICAL Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Sichuan KELUN PHARMACEUTICAL Co, Ltd Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sichuan KELUN PHARMACEUTICAL Co, Ltd Nintedanib Product and Service
-
Table Simcere Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Simcere Pharmaceutical Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Simcere Pharmaceutical Nintedanib Product and Service
-
Table Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chia Tai‑Tianqing Pharmaceutical Holdings Co, Ltd Nintedanib Product and Service
-
Table Shiyao Group Enbipu Pharmaceutical Industry Limited Company (Foundation Year, Company Profile and etc.)
-
Table Shiyao Group Enbipu Pharmaceutical Industry Limited Company Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shiyao Group Enbipu Pharmaceutical Industry Limited Company Nintedanib Product and Service
-
Table Qingfeng Pharmaceutical Industry (Foundation Year, Company Profile and etc.)
-
Table Qingfeng Pharmaceutical Industry Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qingfeng Pharmaceutical Industry Nintedanib Product and Service
-
Table Boehringer Ingelheim Pharma (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Pharma Nintedanib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Pharma Nintedanib Product and Service
-
